Two Sides of Nanovaccines and Nanomedicines in Cancer Treatments
- Publisher's listprice EUR 171.99
-
71 332 Ft (67 936 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 7 133 Ft off)
- Discounted price 64 200 Ft (61 142 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
71 332 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 1 April 2026
- ISBN 9780443445798
- Binding Paperback
- No. of pages486 pages
- Size 276x216 mm
- Weight 450 g
- Language English 700
Categories
Long description:
Two Sides of Nanovaccines and Nanomedicines in Cancer Treatments provides a balanced exploration of the dual roles of nanotechnologies in oncology. Structured in four parts, the book begins with foundational knowledge of nanovaccines and nanomedicines, detailing their applications in cancer care and highlighting their precision in targeting cancer cells while reducing systemic toxicity. Importantly, the book addresses potential drawbacks, discussing side effects and safety concerns associated with these innovations. The final section emphasizes ethical, regulatory, and safety challenges, underscoring the need for careful oversight as nanotechnologies advance.
For the academic audience, this book serves as a vital resource, offering insights that equip researchers and healthcare professionals to make informed decisions regarding clinical applications. Its focus on both benefits and risks, alongside forward-looking perspectives, ensures that readers are well-prepared for future developments in the field of nanomedicine and cancer therapy.
Table of Contents:
Part 1: Fundamentals
1. Introduction to nanovaccine in cancer treatments
2. Introduction to nanomedicine in cancer treatments
3. Sensors for Cancer Detection
4. Current Perspectives of Nanomedicines (in Cancer Treatment)
5. Current Perspectives of Nanovaccines and Nanomedicines (in Cancer Treatment)
Part 2: Advantage and Application of Nanovaccine and Nanomedicine
6. Advantage of cancer Nanomedicine
7. Advantage of Targeted Nanomedicine (in Cancer Treatment)
8. Advantage of nanovaccine (in cancer treatment)
9. Nanovaccines and Nanomedicines in cancer treatment: Current Landscape
Part 3: The Other Side of Nanovaccine and Nanomedicine
10. Side Effect and Toxicity of Nanovaccine (in Cancer Treatment)
11. Side effect and toxicity of nanomedicine (in cancer treatment)
12. Crossing the Barrier, Crossing the Line: Neurotoxicity of Nanomedicines in Brain Cancer Therapy
13. Side effects and toxicity of nanoparticles in cancer treatment
14. Toxicity of Metal Oxide Nanoparticles in Nanomedicine. Mechanisms and Implications
15. Nanotoxicity, safety assessment, regulatory aspect and clinical trial of nanovaccines/nanomedicine
16. Nanotoxicity/nano-genotoxicity in cancer care
17. Toxicity evaluation and management for nanoparticles used in the cancer therapy
18. Nanoparticle Toxicity in Cancer Nanomedicine
Part 4: Challenge and Perspectives
19. Nano-medicines and Nano-vaccines Manufacturing
20. Ethics in Nanomedicine and Nanovaccine in Cancer Treatment
21. Ethics in Cancer Nanomedicine
22. Ethics and regulations in nanomedicine/nanovaccines
23. Regulating nanomedicine: challenges and opportunities
24. Safety Assessment for Nanomedicines and Nanovaccines
25. Manufacturing of nanomedicine/nanovaccine on Large Scale: Challenges and Issues
26. Future perspectives of nanovaccines and nanomedicines
